At a glance
- Originator Chugai Pharmaceutical
- Class Antihyperlipidaemics; Antihypertensives; Benzopyrans; Small molecules; Vasodilators
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 10 Jul 1998 Discontinued-Preclinical for Hypertension in Japan (Unknown route)
- 11 Apr 1995 New profile
- 11 Apr 1995 Preclinical development for Hypertension in Japan (Unknown route)